C12Y304/211

USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
20210386089 · 2021-12-16 ·

The present disclosure provides food supplements comprising proteases that can digest a variety of food proteins to enhance their protein bioavailability in the gut.

USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
20200383351 · 2020-12-10 ·

The present disclosure provides food supplements comprising proteases that can digest a variety of food proteins to enhance their protein bioavailability in the gut.

USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
20240148020 · 2024-05-09 ·

The present disclosure provides food supplements comprising proteases that can digest a variety of food proteins to enhance their protein bioavailability in the gut.

USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
20240315277 · 2024-09-26 ·

The present disclosure provides food supplements comprising proteases that can digest a variety of food proteins to enhance their protein bioavailability in the gut.

PROTEOLYTIC ENZYMES
20260117215 · 2026-04-30 ·

The present disclosure provides proteolytic enzymes, i.e., S53 family proteases, having increased thermostability, increased enzymatic activity, and/or increased substrate specificity and which can digest a variety of food proteins, thereby enhancing a food's protein bioavailability. The S53 family proteases have amino acid sequences that are at least 80% identical to SEQ ID NO: 1 and comprises at least one mutation in the amino acid sequence's 513-loop which corresponds to amino acids 513 to 517 of SEQ ID NO: 1, wherein the at least one mutation is located at position 513, 514, 515, and/or 517.